When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Roseola

Evidence last reviewed: 22 Sep 2026
Topic last updated: 22 Oct 2026

Summary

Definition

History and exam

Key diagnostic factors

  • age under 2 years
  • immunosuppression
  • high fever
  • exanthem
Full details

Other diagnostic factors

  • gastrointestinal symptoms
  • abdominal pain
  • Nagayama spots
  • tympanic membrane inflammation
  • upper respiratory symptoms
  • seizures
  • periorbital edema
  • bulging anterior fontanelle
  • cervical, occipital, or postauricular lymphadenopathy
Full details

Risk factors

  • age under 2 years
  • immunosuppression
Full details

Diagnostic tests

1st tests to order

  • clinical diagnosis
Full details

Tests to consider

  • Human herpesvirus-6- or human herpesvirus-7-specific IgG detection
  • polymerase chain reaction
  • viral culture
  • immunohistochemistry
Full details

Treatment algorithm

ACUTE

all patients

Contributors

Authors

Henry M. Feder, Jr., MD

Professor of Pediatrics and Family Medicine

University of Connecticut Medical Center and Connecticut Children’s

Farmington, CT

Disclosures

HMF declares that he has no competing interests.

Hassan El Chebib, MD, FAAP

Attending Physician in the Division of Infectious Diseases and Immunology

Connecticut Children’s

Assistant Professor of Pediatrics

Pediatrics, Infectious Diseases and Immunology

University of Connecticut School of Medicine

Hartford, CT

Disclosures

HEC declares that he has no competing interests.

Ashley C. Howard, DO

Attending Physician in the Division of Infectious Diseases and Immunology

Connecticut Children’s

Assistant Professor of Pediatrics

Pediatrics, Infectious Diseases and Immunology

University of Connecticut School of Medicine

Hartford, CT

Disclosures

ACH declares that she has no competing interests.

Acknowledgements

Dr Henry M. Feder, Dr Hassan El Chebib, and Dr Ashley C. Howard would like to gratefully acknowledge Dr Edward C. Kim, Dr Nicholas Bennett, Dr James Azim, Dr Margie C. Andreae, Dr Jon Dyer, and Dr Jennifer Holman, the previous contributors to this topic.

Disclosures

ECK, NB, JA, MCA, JD, and JH declare that they have no competing interests.

Peer reviewers

Helen Goodyear, MBChB, MRCP, FRCPCH, MD, MMed

Consultant Paediatrician

Heartlands Hospital

Birmingham

UK

Disclosures

HG declares that she has no competing interests.

Mary T. Caserta, MD

Associate Professor of Pediatrics

Department of Pediatrics

Division of Infectious Diseases

University of Rochester Medical Center

Rochester, NY

Disclosures

MTC declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Hall CB, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children: a prospective study of complications and reactivation. N Engl J Med. 1994 Aug 18;331(7):432-8.Full text  Abstract

Leung AK, Lam JM, Barankin B, et al. Roseola infantum: an updated review. Curr Pediatr Rev. 2024;20(2):119-28. Abstract

Asano Y, Yoshikawa T, Suga S, et al. Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics. 1994;93:104-8. Abstract

Braun DK, Dominguez G, Pellett PE. Human herpesvirus 6. Clin Microbiol Rev. 1997;10:521-67.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Use of this content is subject to our disclaimer